Regulation of T-Cell Chemotaxis by Programmed Death-Ligand 1 (PD-L1) in Dry Eye-Associated Corneal Inflammation

被引:62
|
作者
El Annan, Jaafar [1 ,2 ]
Goyal, Sunali [1 ,2 ]
Zhang, Qiang [1 ,2 ]
Freeman, Gordon J. [3 ]
Sharpe, Arlene H. [4 ]
Dana, Reza [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA
关键词
CHEMOKINE GENE-EXPRESSION; KERATOCONJUNCTIVITIS SICCA; ALLOGRAFT SURVIVAL; ENDOTHELIAL-CELLS; TEAR FLUID; RECEPTOR; MICE; TOLERANCE; SJOGRENS; DISEASE;
D O I
10.1167/iovs.09-3684
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Given that dry eye disease (DED) is associated with T cell-mediated inflammation of the ocular surface and that PD-L1 is an important negative or inhibitory regulator of immune responses constitutively expressed at high levels by corneal epithelial cells, the authors studied the expression and function of PD-L1 in DED. METHODS. Dry eye was induced in untreated wild-type mice, PD-L1(-/-) mice, and wild-type mice treated with anti-PD-L1 antibody by exposing these mice to a desiccating environment in the controlled environment chamber modified with subcutaneous administration of scopolamine. Real-time PCR was used to quantify the expression of chemokine gene transcript levels of multiple CC and CXC chemokine ligands and receptors. Epifluorescence microscopy was used to evaluate corneal infiltration of CD3(+) T cells after immunohistochemical staining. RESULTS. The increased expression of specific chemokine ligands and receptors in PD-L1(-/-) corneas of normal mice is associated with significant increases in T-cell homing into these corneas. Similar, and more enhanced, increases in T-cell infiltration were observed in PD-L1(-/-) DED mice or DED mice treated with anti-PD-L1 antibody compared with controls. In addition, the authors found significantly decreased expression of PD-L1 by corneal epithelial cells in DED and significantly increased corneal fluorescein staining score with PD-L1 functional blockade using anti-PD-L1 antibody. CONCLUSIONS. Downregulation of corneal epithelial PD-L1 amplifies dry eye-associated corneal inflammation and epitheliopathy by increasing the expression of chemokine ligands and receptors that promote T-cell homing to the ocular surface. (Invest Ophthalmol Vis Sci. 2010; 51:3418-3423) DOI:10.1167/iovs.09-3684
引用
收藏
页码:3418 / 3423
页数:6
相关论文
共 50 条
  • [31] Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer
    Gulec, Umran Kucukgoz
    Bagir, Emine Kilic
    Paydas, Semra
    Guzel, Ahmet Baris
    Gumurdulu, Derya
    Vardar, Mehmet Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (02) : 377 - 382
  • [32] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 220 - 220
  • [33] Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA)
    Pedersen, Katrina
    Smyrk, Thomas C.
    Harrington, Susan
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Programmed Death-Ligand 1 (PD-L1) Expression in Upper Tract Urothelial Carcinoma
    Skala, Stephanie
    Liu, Tzu-Ying
    MUdager, Aaron
    Weizei, Alon Z.
    Montgomery, Jeffrey S.
    Palapattu, Ganesh S.
    Siddiqui, Javed
    Cao, Xuhong
    Fields, Kristina
    Abugharib, Ahmed E.
    Soliman, Moaaz
    Hafez, Khaled S.
    Miller, David
    Lee, Cheryl T.
    Alva, Ajjai
    Chinnaiyan, Arul M.
    Morgan, Todd M.
    Sprott, Daniel E.
    Jiang, Hui
    Mehra, Rohit
    LABORATORY INVESTIGATION, 2017, 97 : 260A - 260A
  • [35] Pan-cancer analysis of programmed death-ligand 1 (PD-L1) amplifications
    Budczies, Jan
    Bockmayr, Michael
    Klauschen, Frederick
    Weichert, Wilko
    Denkert, Carsten
    Stenzinger, Albrecht
    CANCER RESEARCH, 2016, 76
  • [36] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Suteau, Valentine
    Collin, Alexandre
    Menei, Philippe
    Rodien, Patrice
    Rousselet, Marie-Christine
    Briet, Claire
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2053 - 2061
  • [37] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [38] Intratumoral programmed cell death-ligand 1 (PD-L1) and Intratumoral CD8+T cell Expression in Lung Cancer
    Jin, Yasuto
    Yamauchi, Shuta
    Shimada, Hiroyuki
    Matsubara, Osamu
    CANCER SCIENCE, 2018, 109 : 1099 - 1099
  • [39] Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD8+ T Cell Expression in Lung Cancer
    Jin, Yasuto
    Matsubara, Osamu
    Yamanaka, Kazuki
    Mark, Eugene
    MODERN PATHOLOGY, 2017, 30 : 481A - 481A
  • [40] Intratumoral Programmed Cell Death-Ligand 1 (PD-L1) and Intratumoral CD8+ T Cell Expression in Lung Cancer
    Jin, Yasuto
    Matsubara, Osamu
    Yamanaka, Kazuki
    Mark, Eugene
    LABORATORY INVESTIGATION, 2017, 97 : 481A - 481A